SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 230 filers reported holding SAGE THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.96 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $311,000 | -53.7% | 1,955 | -72.1% | 0.02% | -62.7% |
| Q4 2018 | $671,000 | +18.8% | 7,000 | +75.0% | 0.05% | +64.5% |
| Q3 2018 | $565,000 | -9.7% | 4,000 | 0.0% | 0.03% | -13.9% |
| Q2 2018 | $626,000 | -35.2% | 4,000 | -33.3% | 0.04% | -28.0% |
| Q1 2018 | $966,000 | -58.1% | 6,000 | -57.1% | 0.05% | -52.8% |
| Q4 2017 | $2,306,000 | +85.1% | 14,000 | -30.0% | 0.11% | +92.7% |
| Q3 2017 | $1,246,000 | -35.6% | 20,000 | -17.7% | 0.06% | -32.9% |
| Q2 2017 | $1,936,000 | -45.1% | 24,300 | -51.1% | 0.08% | -54.2% |
| Q1 2017 | $3,528,000 | -60.4% | 49,650 | -67.5% | 0.18% | -37.2% |
| Q4 2015 | $8,919,000 | – | 152,985 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |